Glenmark Pharmaceuticals Inc USA is set to launch its bioequivalent Potassium Phosphates Injection USP in March 2026. The product, comparable to the Fresenius Kabi version, aims to capture a share of ...
GAINESVILLE, Fla. (WCJB/Gray News) – A family in Florida is suing a hospital after they say their 2-year-old son was accidentally given a fatal dose of potassium phosphate, leading to his death. The ...
Glenmark Pharmaceuticals Inc USA has announced the upcoming launch of Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5 mL and 45 mmol P / 66 mEq K per 15 mL Single-Dose Vials and 150 ...
Asianet Newsable on MSN
Glenmark to launch potassium phosphates injection in the US market
Glenmark Pharmaceuticals will launch Potassium Phosphates Injection USP, a bioequivalent to Fresenius Kabi's drug. The company will begin US distribution in March 2026, entering a market with annual ...
FDA-approved option for adult and pediatric patients available in 15 mM per 5 mL, 45 mM per 15 mL and 150 mM per 50 mL presentations LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results